nach oben

Erschienen in:

11.03.2017 | Original Paper

Examination of the Role of Religious and Psychosocial Factors in HIV Medication Adherence Rates

verfasst von: Safiya George Dalmida, Katryna McCoy, Harold G. Koenig, Aretha Miller, Marcia McDonnell Holstad, Tami Thomas, Dora Clayton-Jones, Mary Grant, Terri Fleming, Menka Munira Wirani, George Mugoya

Erschienen in: Journal of Religion and Health | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Optimal adherence to antiretroviral therapy (ART) is associated with favorable HIV outcomes, including higher CD4 cell counts, HIV virus suppression and a lower risk of HIV transmission. However, only 25% of people living with HIV/AIDS (PLWH) in the USA are virally suppressed. Sub-optimal adherence (<90–95%) contributes to antiretroviral resistance and worse medical outcomes, including more rapid progression to AIDS and death. Psychosocial factors and religion/spirituality (R/S) have a significant impact on ART adherence, but the findings are mixed. The purpose of this study was to examine religious and psychosocial correlates and predictors of ≥90% ART adherence in PLWH. A cross-sectional study was conducted with a sample of 292 outpatient PLWH in the Southeastern USA. Participants completed computerized surveys. The mean ART adherence percentage was 80.9% and only about half reported ≥90% adherence. There were statistically significant differences in ART adherence rates based on age, depressive symptom status and frequency of religious attendance and prayer. Praying at least once a day was significantly associated with ≥90% ART adherence (OR = 2.26, 95% CI [1.06–4.79], p < 0.05). Social support satisfaction was also significantly associated with ART adherence (OR = 1.52, 95% CI [1.11–2.08], p < 0.05) and energy/fatigue/vitality (OR = 1.03, 95% CI [1.00–1.05], p < 0.05).

Bader, A., Kremer, H., Erlich-Trungenberger, I., Rojas, R., Lohmann, M., Deobald, O., et al. (2006). An adherence typology: Coping, quality of life, and physical symptoms of people living with HIV/AIDS and their adherence to antiretroviral treatment. Medical Science Monitor, 12(12), CR493–CR500.PubMed

Balbin, E. G., Ironson, G. H., & Solomon, G. F. (1999). Stress and coping: The psychoneuroimmunology of HIV/AIDS. Best Practice & Research Clinical Endocrinology & Metabolism, 13(4), 615–633.CrossRef

Bangsberg, D. R., Perry, S., Charlebois, E. D., Clark, R. A., Roberston, M., Zolopa, A. R., et al. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. Aids, 15(9), 1181–1183.CrossRefPubMed

Bosworth, H. B. (2006). The importance of spirituality/religion and health-related quality of life among individuals with HIV/AIDS. Journal of General Internal Medicine, 21(S5), S3–S4.CrossRefPubMedPubMedCentral

Castro, K. G., Ward, J. W., Slutsker, L., Buehler, J. W., Jaffe, H. W., Berkelman, R. L., et al. (1993). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Clinical Infectious Diseases, 17(4), 802–810.CrossRef

Centers for Disease Control and Prevention. (2012). CDC Fact Sheet. HIV in the United States: The Stages of Care. Retrieved from www.cdc.gov/hiv/pdf/research_mmp_stagesofcare.pdf.

Chavez, M. (2010). Rain dances in the dry season: Overcoming the religious congruence fallacy. Journal for the Scientific Study of Religion, 49(1), 1–14.CrossRef

Cohen, S., Kamarck, T., & Mermelstein, R. (1983). A global measure of perceived stress. Journal of Health and Social Behavior, 28(4), 385–396.CrossRef

Dalmida, S. G. (2006). Spirituality, mental health, physical health, and health-related quality of life among women with HIV/AIDS: Integrating spirituality into mental health care. Issues Ment Health Nurs, 27(2), 185–198. doi:10.1080/01612840500436958.CrossRefPubMedPubMedCentral

Dalmida, S. G., Holstad, M. M., Diiorio, C., & Laderman, G. (2009). Spiritual well-being, depressive symptoms, and immune status among women living with HIV/AIDS. Women and Health, 49(2–3), 119–143. doi:10.1080/03630240902915036.CrossRefPubMedPubMedCentral

Dalmida, S. G., Holstad, M. M., Diiorio, C., & Laderman, G. (2011). Spiritual well-being and health-related quality of life among african-american women with HIV/AIDS. Applied Research in Quality of Life, 6(2), 139–157. doi:10.1007/s11482-010-9122-6.CrossRefPubMedPubMedCentral

Eaton, J. W., Johnson, L. F., Salomon, J. A., Barnighausen, T., Bendavid, E., Bershteyn, A., et al. (2012). HIV treatment as prevention: Systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Medicine, 9(7), e1001245. doi:10.1371/journal.pmed.1001245.CrossRefPubMedPubMedCentral

Finocchario-Kessler, S., Catley, D., Berkley-Patton, J., Gerkovich, M., Williams, K., Banderas, J., et al. (2011). Baseline predictors of ninety percent or higher antiretroviral therapy adherence in a diverse urban sample: The role of patient autonomy and fatalistic religious beliefs. AIDS Patient Care STDS, 25(2), 103–111.CrossRefPubMedPubMedCentral

Fogarty, L., Roter, D., Larson, S., Burke, J., Gillespie, J., & Levy, R. (2002). Patient adherence to HIV medication regimens: A review of published and abstract reports. Patient Education and Counseling, 46(2), 93–108.CrossRefPubMed

Gardner, E. M., Sharma, S., Peng, G., Hullsiek, K. H., Burman, W. J., Macarthur, R. D., et al. (2008). Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance. Aids, 22(1), 75–82. doi:10.1097/QAD.0b013e3282f366ff.CrossRefPubMedPubMedCentral

Gonzalez, J. S., Batchelder, A. W., Psaros, C., & Safren, S. A. (2011a). Depression and HIV/AIDS treatment nonadherence: A review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 58(2), 181–187. doi:10.1097/QAI.0b013e31822d490a.CrossRefPubMed

Gonzalez, J. S., Psaros, C., Batchelder, A., Applebaum, A., Newville, H., & Safren, S. A. (2011b). Clinician-assessed depression and HAART adherence in HIV-infected individuals in methadone maintenance treatment. Annals of Behavioral Medicine, 42(1), 120–126. doi:10.1007/s12160-011-9268-y.CrossRefPubMedPubMedCentral

Harding, R., Lampe, F. C., Norwood, S., Date, H. L., Clucas, C., Fisher, M., et al. (2010). Symptoms are highly prevalent among HIV outpatients and associated with poor adherence and unprotected sexual intercourse. Sexually Transmitted Infections, 86(7), 520–524. doi:10.1136/sti.2009.038505.CrossRefPubMed

Hays, R. D., Sherbourne, C. D., & Mazel, R. M. (1993). The RAND 36-Item health survey 1.0. Health Economics, 2(3), 217–227.CrossRefPubMed

Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., et al. (2004). Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. Aids, 18(Suppl1), S19–S25.CrossRefPubMedPubMedCentral

Holstad, M. M., Foster, V., Diiorio, C., McCarty, F., & Teplinskiy, I. (2010). An examination of the psychometric properties of the Antiretroviral General Adherence Scale (AGAS) in two samples of HIV-infected individuals. Journal of the Association of Nurses in AIDS Care, 21(2), 162–172. doi:10.1016/j.jana.2009.08.002.CrossRefPubMed

Holstad, M. K., Pace, J. C., De, A. K., & Ura, D. R. (2006). Factors associated with adherence to antiretroviral therapy. Journal of the Association of Nurses in AIDS Care, 17(2), 4–15.CrossRefPubMed

Institute, Fetzer. (1999). Multidimensional measurement of religiousness/spirituality for use in health research: A report of the Fetzer Institute/National Institute on Aging Working Group. Kalamazoo, MI: John E. Fetzer Institute.

Ironson, G., Stuetzle, R., & Fletcher, M. A. (2006). An increase in religiousness/spirituality occurs after HIV diagnosis and predicts slower disease progression over 4 years in people with HIV. Journal of General Internal Medicine, 21(Suppl 5), S62–S68. doi:10.1111/j.1525-1497.2006.00648.x.CrossRefPubMedPubMedCentral

Kaldjian, L. C., Jekel, J. F., & Friedland, G. (1998). End-of-life decisions in HIV-positive patients: The role of spiritual beliefs. AIDS, 12(1), 103–107.CrossRefPubMed

Kisenyi, R. N., Muliira, J. K., & Ayebare, E. (2013). Religiosity and adherence to antiretroviral therapy among patients attending a public hospital-based HIV/AIDS clinic in Uganda. Journal of Religion and Health, 52(1), 307–317.CrossRefPubMed

Koenig, H. G. (1998). Religious attitudes and practices of hospitalized medically ill older adults. International Journal of Geriatric Psychiatry, 13(4), 213–224.CrossRefPubMed

Koenig, H., & Cohen, H. J. E. (2002). The link between religion and health: Psychoneuroimmunology and the faith factor. Oxford: Oxford University Press.CrossRef

Koenig, H. G., George, L. K., & Siegler, I. C. (1988). The use of religion and other emotion-regulating coping strategies among older adults. Gerontologist, 28(3), 303–310.CrossRefPubMed

Konkle-Parker, D. J., Erlen, J. A., & Dubbert, P. M. (2008). Barriers and facilitators to medication adherence in a southern minority population with HIV disease. Journal of the Association of Nurses in AIDS Care, 19(2), 98–104.CrossRefPubMedPubMedCentral

Kremer, H., Ironson, G., & Porr, M. (2009). Spiritual and mind–body beliefs as barriers and motivators to HIV-treatment decision-making and medication adherence? A qualitative study. AIDS Patient Care STDS, 23(2), 127–134.CrossRefPubMedPubMedCentral

Kremer, H., Ironson, G., Schneiderman, N., & Hautzinger, M. (2006). To take or not to take: Decision-making about antiretroviral treatment in people living with HIV/AIDS. AIDS Patient Care & STDs, 20(5), 335–349.CrossRef

Liu, H., Miller, L. G., Hays, R. D., Golin, C. E., Wu, T., Wenger, N. S., et al. (2006). Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors. Journal of Acquired Immune Deficiency Syndromes, 41(3), 315–322. doi:10.1097/01.qai.0000197071.77482.6e.CrossRefPubMed

Lorenz, K. A., Hays, R. D., Shapiro, M. F., Cleary, P. D., Asch, S. M., & Wenger, N. S. (2005). Religiousness and spirituality among HIV-infected Americans. Journal of Palliative Medicine, 8(4), 774–781. doi:10.1089/jpm.2005.8.774.CrossRefPubMed

Lyimo, R. A., Stutterheim, S. E., Hospers, H. J., de Glee, T., van der Ven, A., & de Bruin, M. (2014). Stigma, disclosure, coping, and medication adherence among people living with HIV/AIDS in Northern Tanzania. AIDS Patient Care STDS, 28(2), 98–105.CrossRefPubMed

Maman, S., Cathcart, R., Burkhardt, G., Omba, S., & Behets, F. (2009). The role of religion in HIV-positive women’s disclosure experiences and coping strategies in Kinshasa, Democratic Republic of Congo. Social Science and Medicine, 68(5), 965–970.CrossRefPubMed

Mannheimer, S., Thackeray, L., Huppler Hullsiek, K., Chesney, M., Gardner, E. M., Wu, A. W., et al. (2008). A randomized comparison of two instruments for measuring self-reported antiretroviral adherence. AIDS Care, 20(2), 161–169. doi:10.1080/09540120701534699.CrossRefPubMed

Miles, M. S., Burchinal, P., Holditch-Davis, D., Wasilewski, Y., & Christian, B. (1997). Personal, family, and health-related correlates of depressive symptoms in mothers with HIV. Journal of Family Psychology, 11(1), 23.CrossRef

Montaner, J. S., Reiss, P., Cooper, D., Vella, S., Harris, M., Conway, B., et al. (1998). A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: The INCAS Trial. Italy, The Netherlands, Canada and Australia Study. JAMA, 279(12), 930–937.CrossRefPubMed

Nguyen, V. K., Bajos, N., Dubois-Arber, F., O’Malley, J., & Pirkle, C. M. (2011). Remedicalizing an epidemic: From HIV treatment as prevention to HIV treatment is prevention. Aids, 25(3), 291–293. doi:10.1097/QAD.0b013e3283402c3e.CrossRefPubMed

O’brien, R. M. (2007). A caution regarding rules of thumb for variance inflation factors. Quality & Quantity, 41(5), 673–690.CrossRef

Pargament, K. I., Smith, B. W., Koenig, H. G., & Perez, L. (1998). Patterns of positive and negative religious coping with major life stressors. Journal for the Scientific Study of Religion, 37(4), 710–724.CrossRef

Parsons, S. K., Cruise, P. L., Davenport, W. M., & Jones, V. (2006). Religious beliefs, practices and treatment adherence among individuals with HIV in the Southern United States. AIDS Patient Care & STDs, 20(2), 97–111.CrossRef

Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(1), 21–30.CrossRefPubMed

Radloff, L. S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurements, 1, 385–401.CrossRef

Radloff, L. S., & Locke, B. Z. (1986). The community mental health assessment survey and CES-D scale. In M. M. Weissman & J. K. Meyers (Eds.), Community surveys of psychiatric disorders (pp. 177–187). New Brunswick, NJ: Rutgers University Press.

Roura, M., Nsigaye, R., Nhandi, B., Wamoyi, J., Busza, J., Urassa, M., et al. (2010). Driving the devil away”: Qualitative insights into miraculous cures for AIDS in a rural Tanzanian ward. BMC Public Health, 10(1), 427.CrossRefPubMedPubMedCentral

Safren, S. A., Otto, M. W., & Worth, J. L. (1999). Life-steps: Applying cognitive behavioral therapy to HIV medication adherence. Cognitive and Behavioral Practice, 6(4), 332–341. doi:10.1016/S1077-7229(99)80052-2.CrossRef

Safren, S. A., Otto, M. W., Worth, J. L., Salomon, E., Johnson, W., Mayer, K., et al. (2001). Two strategies to increase adherence to HIV antiretroviral medication: Life-steps and medication monitoring. Behaviour Research and Therapy, 39(10), 1151–1162.CrossRefPubMed

Sarason, I. G., Sarason, B. R., Shearin, E. N., & Pierce, G. R. (1987). A brief measure of social support: Practical and theoretical implications. Journal of Social and Personal Relationships, 4, 497–510.CrossRef

Sherr, L., Clucas, C., Harding, R., Sibley, E., & Catalan, J. (2011). HIV and depression–a systematic review of interventions. Psychol Health Med, 16(5), 493–527. doi:10.1080/13548506.2011.579990.CrossRefPubMed

Stansell, J., Holtzer, C., Mayer, S., DeGuzman, D., Hamel, E., & Lapins, D. (2001). Factors affecting treatment outcomes in a medication event monitoring system. Paper presented at the Retroviruses and Opportunistic Infections, Chicago, Ill.

Tarakeshwar, N., Khan, N., & Sikkema, K. J. (2006). A relationship-based framework of spirituality for individuals with HIV. AIDS and Behavior, 10(1), 59–70. doi:10.1007/s10461-005-9052-8.CrossRefPubMed

Thielman, N. M., Ostermann, J., Whetten, K., Whetten, R., Itemba, D., Maro, V., et al. (2014). Reduced adherence to antiretroviral therapy among HIV-Infected Tanzanians seeking cure from the Loliondo Healer. JAIDS Journal of Acquired Immune Deficiency Syndromes, 65(3), e104–e109.CrossRefPubMed

Tumwine, C., Neema, S., & Wagner, G. (2012). Reasons why high religiosity can co-exist with and precipitate discontinuation of anti-retroviral therapy among different HIV clients in Uganda: An exploratory study. Religions, 3(3), 817–832.CrossRefPubMedPubMedCentral

Vedhara, K., Schifitto, G., & McDermott, M. (1999). Disease progression in HIV-positive women with moderate to severe immunosuppression: The role of depression. Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. Behavioral Medicine, 25(1), 43–47. doi:10.1080/08964289909596738.CrossRefPubMed

Vyas, K. J., Limneos, J., Qin, H., & Mathews, W. C. (2014). Assessing baseline religious practices and beliefs to predict adherence to highly active antiretroviral therapy among HIV-infected persons. AIDS Care, 26(8), 983–987.CrossRefPubMed

Wanyama, J., Castelnuovo, B., Wandera, B., Mwebaze, P., Kambugu, A., Bangsberg, D. R., et al. (2007). Belief in divine healing can be a barrier to antiretroviral therapy adherence in Uganda. Aids, 21(11), 1486–1487.CrossRefPubMed

Titel: Examination of the Role of Religious and Psychosocial Factors in HIV Medication Adherence Rates
verfasst von: Safiya George Dalmida
Katryna McCoy
Harold G. Koenig
Aretha Miller
Marcia McDonnell Holstad
Tami Thomas
Dora Clayton-Jones
Mary Grant
Terri Fleming
Menka Munira Wirani
George Mugoya
Publikationsdatum: 11.03.2017
Verlag: Springer US
Erschienen in: Journal of Religion and Health / Ausgabe 6/2017
Print ISSN: 0022-4197
Elektronische ISSN: 1573-6571
DOI: https://doi.org/10.1007/s10943-017-0377-1

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Examination of the Role of Religious and Psychosocial Factors in HIV Medication Adherence Rates

Abstract

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2017

Is Spiritual Well-Being Among Adolescents Associated with a Lower Level of Bullying Behaviour? The Mediating Effect of Perceived Bullying Behaviour of Peers

Integrating Spiritual Care into Palliative Consultation: A Case Study in Expanded Practice

Cancer-Induced Bone Pain Management Through Buddhist Beliefs

Research on Intercessory Prayer: Theoretical and Methodological Considerations

The Prevalence and Antecedents of Religious Beliefs About Health Control in the US Population: Variations by Race and Religious Background

Divine Emotions: On the Link Between Emotional Intelligence and Religious Belief